OpGen, In-Q-Tel Developing Technology for Microbial Genome Analysis | GenomeWeb

NEW YORK (GenomeWeb News) – OpGen today announced a collaboration with In-Q-Tel to develop a high-throughput sequence and genome mapping pipeline for microbial genome analysis.

The firms are developing the technology for the US Department of Homeland Security Science and Technology Directorate, a customer agency of In-Q-Tel, and the National Bioforensic Analysis Center, a DHS S&T laboratory.

In-Q-Tel, based in Arlington, Va., is an independent strategic investment firm that identifies technologies that support the missions of the US intelligence community.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.